| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160180 Cannabinoid Receptor Ligands |
| 06/30/2011 | US20110160179 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160162 Prodrugs of a2b adenosine receptor antagonists |
| 06/30/2011 | US20110160161 Concentrated therapeutic phospholipid compositions |
| 06/30/2011 | US20110160157 Methods of treating an inflammatory-related disease |
| 06/30/2011 | US20110160156 Pharmaceutical Composition for the Eradication of Helicobacter Pylori and Preparation Method Thereof |
| 06/30/2011 | US20110160130 Cancer treatment method |
| 06/30/2011 | US20110160120 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110160118 Methods and compositions for treating oral and esophageal lesions |
| 06/30/2011 | US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
| 06/30/2011 | US20110159120 Synergistic anti-inflammatory compositions comprising boswellia serrata extracts |
| 06/30/2011 | US20110159058 Film preparation containing loperamide hydrochloride |
| 06/30/2011 | US20110159048 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
| 06/30/2011 | US20110158983 Compositions and methods for mucositis and oncology therapies |
| 06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158966 Stem cells characterized by expression of germline specific genes |
| 06/30/2011 | US20110158962 Dental pulp marrow similar cells (dpmsc) and methods of isolating and using |
| 06/30/2011 | US20110158951 Use of blood group status ii |
| 06/30/2011 | US20110158950 Use of blood group status i |
| 06/30/2011 | US20110158949 Metabolically active micro organisms and methods for their production |
| 06/30/2011 | US20110158933 Liver function and treatment of liver disease |
| 06/30/2011 | US20110158930 Method for treatment of irritable bowel syndrome |
| 06/30/2011 | US20110158918 Oral cavity stimulating substance |
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | CA2785434A1 Treatment for inflammatory bowel disease |
| 06/30/2011 | CA2785268A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof |
| 06/30/2011 | CA2784944A1 Synergic action of a prolyl protease and tripeptidyl proteases |
| 06/30/2011 | CA2784723A1 Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/29/2011 | EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 06/29/2011 | EP2338475A2 Treating canker sores with patches to speed healing and relieve pain |
| 06/29/2011 | EP2337569A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| 06/29/2011 | EP1883645B1 Derivatives of 4-or 5-aminosalicylic acid |
| 06/29/2011 | EP1499313B1 Heterocyclic derivatives as opioid receptor modulators |
| 06/29/2011 | EP1180546B1 Human cell lines showing stable expression of cytochromes p450 |
| 06/29/2011 | CN1918298B Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 06/29/2011 | CN1895520B Gastrin magnesium granules and preparation thereof |
| 06/29/2011 | CN1834090B Benzimidazole compounds, its preparation and uses |
| 06/29/2011 | CN1812794B Medicinal composition in solution form |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112473A Pyrrolidinyl-alkyl-amide derivatives, their preparation and their therapeutic application as ccr3 receptor ligands |
| 06/29/2011 | CN102112148A Use of cell-permeable peptide inhibitors of jnk signal transduction pathway for treatment of chronic or non-chronic inflammatory digestive diseases |
| 06/29/2011 | CN102112129A Thiazole compounds, and compositions and methods using same |
| 06/29/2011 | CN102112101A Therapeutic and prophylactic formulation for oral care |
| 06/29/2011 | CN102108356A Novel promoter and virus vector containing same |
| 06/29/2011 | CN102108350A Preparation method of bromelin |
| 06/29/2011 | CN102108346A Method for preparing lysozyme |
| 06/29/2011 | CN102108090A Dihydroiso-coumarin glucoside compounds and preparation method and application thereof |
| 06/29/2011 | CN102108077A Method for preparing dexlansoprazole |
| 06/29/2011 | CN102107010A Ondansetron hydrochloride medicament resin complex and application thereof |
| 06/29/2011 | CN102107002A Compound trimebutine maleate composition and preparation method thereof |
| 06/29/2011 | CN102107001A Application of LXR nuclear receptor agonist in treatment and prevention of autoimmune diseases |
| 06/29/2011 | CN102106993A Chinese medicinal composition for treating fatty liver and preparation method thereof |
| 06/29/2011 | CN102106992A Chinese medicinal granules for treating non-alcoholic steatohepatitis |
| 06/29/2011 | CN102106990A Chinese medicinal preparation for treating hepatitis |
| 06/29/2011 | CN102106989A Chinese medicinal oral decoction for treating astriction |
| 06/29/2011 | CN102106984A Medicinal composition for treating pernicious vomiting and fetal irritability |
| 06/29/2011 | CN102106982A Chinese medicinal composition for treating chronic hepatitis B in immune clearance phase |
| 06/29/2011 | CN102106973A Medicament for treating chronic enteritis |
| 06/29/2011 | CN102106971A Chinese medicinal oral administration decoction for treating chronic gastritis |
| 06/29/2011 | CN102106970A Crocodile gall wine as well as preparation method and use thereof |
| 06/29/2011 | CN102106969A Traditional Chinese medicine for treating deficiency constipation |
| 06/29/2011 | CN102106962A Chinese medicinal composition for treating gastric cancer |
| 06/29/2011 | CN102106952A Infused drink for treating chronic diarrhea |
| 06/29/2011 | CN102106934A Natural deodorant for controlling intestinal function and preparation method thereof |
| 06/29/2011 | CN102106930A Mixture with antioxidant and liver-protecting functions and manufacturing method thereof |
| 06/29/2011 | CN102106926A Chinese medicinal composition for immunoregulation of chronic hepatitis B in inactive phase or carrier state |
| 06/29/2011 | CN102106925A Medlar polysaccharide and bifidobacterium snybiotic colonic targeting microecological regulator |
| 06/29/2011 | CN102106918A Method for simultaneously preparing volatile oil, total flavones and total alkaloids from immature bitter oranges |
| 06/29/2011 | CN102106917A Method for measuring content of hesperidin in ventilation pill through high-performance liquid chromatograph |
| 06/29/2011 | CN102106916A Traditional Chinese medicament for anus exhaust after abdominal operation |
| 06/29/2011 | CN102106913A Chinese medicinal composition for activating immunological tolerance period of chronic hepatitis B |
| 06/29/2011 | CN102106911A Application of green apple juice in preparing health care product for preventing and treating halitosis |
| 06/29/2011 | CN102106907A Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process |
| 06/29/2011 | CN102106906A Traditional Chinese medicine composition and preparations thereof for freshening breath and cleansing oral cavities |
| 06/29/2011 | CN102106903A Application of dementholised peppermint oil to preparation of medicament for treating post-cholecystectomy blocked dynamic |
| 06/29/2011 | CN102106899A Origanum oil emulsion and preparation process thereof |
| 06/29/2011 | CN102106894A Application of immature cucumber juice in preparation of healthcare products for preventing and treating halitosis |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106880A Method for preparing injection liquid for treating infection of digestive systems and urinary systems of animals |
| 06/29/2011 | CN102106868A Therapeutic agent for periodontal diseases and method of treating periodontal diseases |
| 06/29/2011 | CN102106852A Medicinal use of 2'2-bithiazole non-nucleoside compounds serving as hepatitis C virus inhibitor |
| 06/29/2011 | CN102106838A Sulfasalazine enteric-coated preparation and preparation method thereof |
| 06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
| 06/29/2011 | CN102106829A Sodium rabeprazole freeze-dried powder injection for injection, preparation method thereof and detection method thereof |
| 06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
| 06/29/2011 | CN102106818A Isoliquiritigenin micro-emulsion composition |
| 06/29/2011 | CN102106813A Sodium new neohouttuyfonate injection and preparation method and application thereof |
| 06/29/2011 | CN102106462A Additive for reducing methane release of ruminant rumen |
| 06/29/2011 | CN102106420A Method for processing camellia nitidissima granules |